NCT02147548View on ClinicalTrials.gov

Evaluation of the Effects of Etifoxine 100 mg and Lorazepam 2 mg on Vigilance and Cognitive Functions in the Elderly

PHASE3CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Healthy Volunteers
Interventions
DRUG

etifoxine

DRUG

lorazepam

DRUG

Placebo

Trial Locations (1)

59037

Centre d'Investigation Clinique, CIC 1403 INSERM/CHRU, Lille

Sponsors

Lead Sponsor

Biocodex
All Listed Sponsors
lead

Biocodex

INDUSTRY

NCT02147548 - Evaluation of the Effects of Etifoxine 100 mg and Lorazepam 2 mg on Vigilance and Cognitive Functions in the Elderly | Biotech Hunter | Biotech Hunter